217 related articles for article (PubMed ID: 21160623)
1. Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.
Voutsadakis IA
World J Gastrointest Oncol; 2010 May; 2(5):235-41. PubMed ID: 21160623
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.
Stravodimou A; Mazzoccoli G; Voutsadakis IA
PPAR Res; 2012; 2012():367450. PubMed ID: 23049538
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis.
Voutsadakis IA
J Cancer Res Clin Oncol; 2007 Dec; 133(12):917-28. PubMed ID: 17659359
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor γ and colorectal cancer.
Dai Y; Wang WH
World J Gastrointest Oncol; 2010 Mar; 2(3):159-64. PubMed ID: 21160824
[TBL] [Abstract][Full Text] [Related]
5. The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II.
Sun L; Bian K
Int J Biol Sci; 2019; 15(6):1215-1224. PubMed ID: 31223281
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes.
Floyd ZE; Stephens JM
J Biol Chem; 2002 Feb; 277(6):4062-8. PubMed ID: 11733495
[TBL] [Abstract][Full Text] [Related]
8. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
[TBL] [Abstract][Full Text] [Related]
9. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
10. Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.
Zhai X; Qiao H; Guan W; Li Z; Cheng Y; Jia X; Zhou Y
Eur J Pharmacol; 2015 Jan; 746():56-62. PubMed ID: 25445048
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility.
Santoro M; De Amicis F; Aquila S; Bonofiglio D
Hum Reprod; 2020 Sep; 35(9):2072-2085. PubMed ID: 32766764
[TBL] [Abstract][Full Text] [Related]
12. 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway.
Hsi LC; Wilson L; Nixon J; Eling TE
J Biol Chem; 2001 Sep; 276(37):34545-52. PubMed ID: 11447213
[TBL] [Abstract][Full Text] [Related]
13. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
Genini D; Catapano CV
J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells.
Ramos de Carvalho JE; Verwoert MT; Vogels IMC; Reits EA; Van Noorden CJF; Klaassen I; Schlingemann RO
Biochem Biophys Rep; 2018 Mar; 13():83-92. PubMed ID: 29387813
[TBL] [Abstract][Full Text] [Related]
16. Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.
Genini D; Carbone GM; Catapano CV
PPAR Res; 2008; 2008():195065. PubMed ID: 18551186
[TBL] [Abstract][Full Text] [Related]
17. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2.
Voutsadakis IA
J Cell Mol Med; 2007; 11(2):252-85. PubMed ID: 17488476
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer.
Linsalata M; Giannini R; Notarnicola M; Cavallini A
BMC Cancer; 2006 Jul; 6():191. PubMed ID: 16854216
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
